Frankfurt - Delayed Quote EUR
Zevra Therapeutics, Inc. (1GDA.F)
7.60
-0.15
(-1.94%)
At close: June 6 at 8:01:03 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 7 | 6 | 7 |
| Avg. Estimate | 22.49M | 24.29M | 93.17M | 161.58M |
| Low Estimate | 20.6M | 22.2M | 87M | 114.6M |
| High Estimate | 24.3M | 26.1M | 99.4M | 232M |
| Year Ago Sales | 4.45M | 3.69M | 23.61M | 93.17M |
| Sales Growth (year/est) | 405.53% | 557.40% | 294.60% | 73.42% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1GDA.F | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.48% | 7.55% | 14.01% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 5/14/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 3/13/2025 |
| Maintains | Guggenheim: Buy to Buy | 3/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/13/2025 |
| Maintains | Citizens Capital Markets: Market Outperform to Market Outperform | 3/12/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 3/12/2025 |